⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27784783 | 1.00 | — | — | |
| SCHEMBL3338549 | 1.00 | — | — | |
| SCHEMBL706082 | 1.00 | — | — | |
| SCHEMBL647320 | 1.00 | — | — | |
| SCHEMBL315171 | 1.00 | — | — | |
| SCHEMBL1289864 | 1.00 | — | — | |
| SCHEMBL10891818 | 1.00 | — | — | |
| SCHEMBL1669744 | 1.00 | — | — | |
| SCHEMBL21880102 | 1.00 | — | — | |
| Fluoride SCHEMBL4973760 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6817211-B2 | HIGH PURITY DIRECT DEPOSIT VITRIFIED SILICON OXYFLUORIDE GLASS SUITABLE FOR USE AS A PHOTOMASK SUBSTRATES FOR PHOTOLITHOGRAPHY APPLICATIONS IN THE VUV WAVELENGTH REGION BELOW 190 NM IS DISCLOSED. THE INVENTIVE DIRECT DEPOSIT | CORNING INCORPORATED | 2004-11-16 | — | — | US | claimed |
| US-6732551-B2 | Method and feedstock for making silica | CORNING INCORPORATED | 2004-05-11 | — | — | US | claimed |
| EP-0729954-B1 | Substituted thiophene sulfonyl ureas and thioureas, process for their preparation, their use as medicaments | HOECHST AG (DE) | 2003-09-03 | — | — | EP | claimed |
| US-20030148194-A1 | Vacuum ultraviolet transmitting direct deposit vitrified silicon oxyfluoride lithography glass photomask blanks | BROWN JOHN T (US) | 2003-08-07 | — | — | US | claimed |
| EP-1330680-A1 | VACUUM ULTRAVIOLET TRANSMITTING DIRECT DEPOSIT VITRIFIED SILICON OXYFLUORIDE LITHOGRAPHY GLASS PHOTOMASK BLANKS | CORNING INCORPORATED (US) | 2003-07-30 | — | — | EP | claimed |
| US-6506937-B2 | Used as antiarrhythmics | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2003-01-14 | — | — | US | claimed |
| WO-2002090273-A1 | METHOD AND USE OF A FEEDSTOCK FOR MAKING SILICA GLASS | CORNING INCORPORATED (US) | 2002-11-14 | — | — | WO | claimed |
| US-20020162359-A1 | Method and feedstock for making silica | CORNING INCORPORATED | 2002-11-07 | — | — | US | claimed |
| US-20020058838-A1 | Substituted benzenesulfonylureas and -thioureas-processes for their preparation and their use as pharmaceuticals | HOECHST AKTIENGESELLSCHAFT | 2002-05-16 | — | — | US | claimed |
| WO-2002021217-A1 | VACUUM ULTRAVIOLET TRANSMITTING DIRECT DEPOSIT VITRIFIED SILICON OXYFLUORIDE LITHOGRAPHY GLASS PHOTOMASK BLANKS | CORNING INCORPORATED (US) | 2002-03-14 | — | — | WO | claimed |
| EP-0727416-B1 | Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use as medicament or diagnostic agent, as well as medicaments containing them | HOECHST AG (DE) | 2000-01-26 | — | — | EP | claimed |
| EP-0657423-B1 | Aminosubstituted benzoylsulfonylurea and thiourea derivatives, process for their preparation and their use as pharmaceuticals | HOECHST AG (DE) | 1998-12-30 | — | — | EP | claimed |
| US-5792788-A | FOR TREATMENT OF CARDIAC DISORDERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-08-11 | — | — | US | claimed |
| US-5698596-A | ANTIARRHYTHMIA AGENTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-12-16 | — | — | US | claimed |
| EP-0558635-B1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED INC (US) | 1997-09-10 | — | — | EP | claimed |
| US-5652268-A | TREATING CARDIOVASCULAR DISORDERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-07-29 | — | — | US | claimed |
| EP-0612724-B1 | Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use as pharmaceuticals | HOECHST AG (DE) | 1996-12-27 | — | — | EP | claimed |
| EP-0558635-A4 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | — | 1993-11-24 | — | — | EP | claimed |
| EP-0558635-A1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS. | GLYCOMED INC (US) | 1993-09-08 | — | — | EP | claimed |
| WO-1992009563-A1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED, INC. (US) | 1992-06-11 | — | — | WO | claimed |